Results for tag: "Nephrotic Syndrome Drug"

The Nephrotic Syndrome Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. Nephrotic Syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. Treatment for Nephrotic Syndrome typically involves the use of corticosteroids, immunosuppressants, and other drugs. These drugs are used to reduce inflammation, suppress the immune system, and reduce the amount of protein in the urine. In some cases, surgery may be necessary to remove damaged tissue. The Nephrotic Syndrome Drug market is highly competitive, with many companies offering a variety of treatments. Companies such as AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi are all major players in the market. Other companies such as Allergan, Amgen, Biogen, Celgene, Eli Lilly, and Regeneron are also active in the market. Show Less Read more